Successful Implantation of an Intrathecal Drug Delivery System in an Immunocompromised Patient: A Case Report

Intrathecal drug delivery systems are becoming increasingly utilized for malignant and non-malignant chronic pain

Intrathecal drug delivery systems are relatively safe and efficacious system with relatively few adverse effects. 

However, complications including infection are still a major concern. 

Careful consideration is needed prior to placement in patients who are immunocompromised and at high risk for infections, including patients with a history of cancer or transplantation.